1. Home
  2. PCRX vs LEGH Comparison

PCRX vs LEGH Comparison

Compare PCRX & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • LEGH
  • Stock Information
  • Founded
  • PCRX 2006
  • LEGH 2005
  • Country
  • PCRX United States
  • LEGH United States
  • Employees
  • PCRX N/A
  • LEGH N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • LEGH Homebuilding
  • Sector
  • PCRX Health Care
  • LEGH Consumer Discretionary
  • Exchange
  • PCRX Nasdaq
  • LEGH Nasdaq
  • Market Cap
  • PCRX 1.2B
  • LEGH 588.8M
  • IPO Year
  • PCRX 2011
  • LEGH 2018
  • Fundamental
  • Price
  • PCRX $23.22
  • LEGH $23.97
  • Analyst Decision
  • PCRX Buy
  • LEGH Strong Buy
  • Analyst Count
  • PCRX 9
  • LEGH 2
  • Target Price
  • PCRX $29.89
  • LEGH $29.00
  • AVG Volume (30 Days)
  • PCRX 560.0K
  • LEGH 102.9K
  • Earning Date
  • PCRX 07-29-2025
  • LEGH 08-07-2025
  • Dividend Yield
  • PCRX N/A
  • LEGH N/A
  • EPS Growth
  • PCRX N/A
  • LEGH 8.04
  • EPS
  • PCRX N/A
  • LEGH 2.29
  • Revenue
  • PCRX $702,772,000.00
  • LEGH $176,618,000.00
  • Revenue This Year
  • PCRX $7.54
  • LEGH N/A
  • Revenue Next Year
  • PCRX $10.78
  • LEGH $8.23
  • P/E Ratio
  • PCRX N/A
  • LEGH $10.47
  • Revenue Growth
  • PCRX 3.08
  • LEGH N/A
  • 52 Week Low
  • PCRX $11.16
  • LEGH $21.58
  • 52 Week High
  • PCRX $27.64
  • LEGH $29.31
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 34.52
  • LEGH 63.30
  • Support Level
  • PCRX $22.82
  • LEGH $21.91
  • Resistance Level
  • PCRX $24.36
  • LEGH $24.17
  • Average True Range (ATR)
  • PCRX 0.69
  • LEGH 0.61
  • MACD
  • PCRX -0.12
  • LEGH 0.27
  • Stochastic Oscillator
  • PCRX 12.39
  • LEGH 89.96

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.

Share on Social Networks: